Intas

Intas, established in 1977, is a prominent global pharmaceutical company specializing in the manufacturing and research of high-quality medicines. With a strong focus on integrated pharmaceutical solutions, Intas serves diverse healthcare needs across human and animal sectors. The company's operations span multiple continents, driven by a commitment to innovation and accessibility in healthcare. Its core business encompasses the development and commercialization of a wide range of pharmaceutical formulations, positioning it as a key player in the global biopharmaceutical market.

Operating with a significant workforce of over 10,000 employees, Intas maintains a robust operational footprint across three primary locations. This extensive team is dedicated to advancing pharmaceutical science and ensuring the delivery of essential medical products. The company's scale and reach are supported by a comprehensive organizational structure, enabling it to manage complex research, development, and manufacturing processes efficiently. Meet Intas's team to understand the expertise driving its global initiatives and product development pipeline.

Intas generates substantial revenue, reported at $2.3 billion, reflecting its strong market presence and commercial success. The company has also secured significant funding, including a $106.3 million round in 2017 from Capital Group, further bolstering its growth and expansion strategies. Its product portfolio includes pharmaceuticals, formulations, and animal healthcare solutions, catering to a broad spectrum of market demands. For detailed financial performance and investment insights, explore Explore financial highlights.